These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21377719)

  • 1. Recombinant allergens for specific immunotherapy.
    Cromwell O; Häfner D; Nandy A
    J Allergy Clin Immunol; 2011 Apr; 127(4):865-72. PubMed ID: 21377719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current state of recombinant allergens for immunotherapy.
    Pauli G; Malling HJ
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-tailored recombinant allergen products--mission impossible?
    Cromwell O; Matricardi PM; Fiebig H
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():210-7; discussion 217-8. PubMed ID: 20799463
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific immunotherapy : clinical experience with recombinant molecular major allergens and hypoallergenic variants].
    Schendzielorz P; Klimek L
    HNO; 2013 Oct; 61(10):834-42. PubMed ID: 23913191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant allergens for pollen immunotherapy.
    Wallner M; Pichler U; Ferreira F
    Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for recombinant allergen vaccines and fruitful results from first clinical studies.
    Cromwell O; Fiebig H; Suck R; Kahlert H; Nandy A; Kettner J; Narkus A
    Immunol Allergy Clin North Am; 2006 May; 26(2):261-81, vii. PubMed ID: 16701144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and recombinant immunotherapy.
    Larché M
    Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
    Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R
    J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients.
    Marogna M; Spadolini I; Massolo A; Zanon P; Berra D; Chiodini E; Canonica WG; Passalacqua G
    Ann Allergy Asthma Immunol; 2007 Mar; 98(3):274-80. PubMed ID: 17378260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.